118 related articles for article (PubMed ID: 27797288)
1. Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting.
Joseph AM; Manseau MW; Lalane M; Rajparia A; Lewis CF
Am J Drug Alcohol Abuse; 2017 Jan; 43(1):117-122. PubMed ID: 27797288
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric Emergency Setting.
Manseau MW; Rajparia A; Joseph A; Azarchi S; Goff D; Satodiya R; Lewis CF
Subst Use Misuse; 2017 May; 52(6):822-825. PubMed ID: 28156305
[TBL] [Abstract][Full Text] [Related]
3. A Polydrug and Psychosocial Profile of Synthetic Cannabinoid Use in a New York City Community Sample, 2016-2017.
Joseph A; Lekas HM; Manseau M; Lewis C
Subst Use Misuse; 2019; 54(2):282-287. PubMed ID: 30526203
[TBL] [Abstract][Full Text] [Related]
4. Synthetic cannabinoid use among patients in residential substance use disorder treatment: prevalence, motives, and correlates.
Bonar EE; Ashrafioun L; Ilgen MA
Drug Alcohol Depend; 2014 Oct; 143():268-71. PubMed ID: 25096272
[TBL] [Abstract][Full Text] [Related]
5. Synthetic cannabinoid use among college students.
Mathews EM; Jeffries E; Hsieh C; Jones G; Buckner JD
Addict Behav; 2019 Jun; 93():219-224. PubMed ID: 30772774
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographic and clinical characteristics of synthetic cannabinoid users in a large psychiatric emergency department in Turkey.
Yalçın M; Tunalı N; Yıldız H; Oğuz A; Gültekin BK
J Addict Dis; 2018; 37(3-4):259-267. PubMed ID: 31581902
[TBL] [Abstract][Full Text] [Related]
7. The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products.
Winstock AR; Barratt MJ
Hum Psychopharmacol; 2013 Jul; 28(4):390-3. PubMed ID: 23881887
[TBL] [Abstract][Full Text] [Related]
8. Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana.
Clayton HB; Lowry R; Ashley C; Wolkin A; Grant AM
Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28289138
[TBL] [Abstract][Full Text] [Related]
9. Novel psychoactive drug use among younger adults involved in US nightlife scenes.
Kelly BC; Wells BE; Pawson M; Leclair A; Parsons JT; Golub SA
Drug Alcohol Rev; 2013 Nov; 32(6):588-93. PubMed ID: 23795887
[TBL] [Abstract][Full Text] [Related]
10. Synthetic cannabinoid withdrawal: a new demand on detoxification services.
Macfarlane V; Christie G
Drug Alcohol Rev; 2015 Mar; 34(2):147-53. PubMed ID: 25588420
[TBL] [Abstract][Full Text] [Related]
11. Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015.
Keyes KM; Rutherford C; Hamilton A; Palamar JJ
Drug Alcohol Depend; 2016 Sep; 166():159-67. PubMed ID: 27491817
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
Besli GE; Ikiz MA; Yildirim S; Saltik S
J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
[TBL] [Abstract][Full Text] [Related]
13. Clinical and financial implications of emergency department visits for synthetic marijuana.
Rowley E; Benson D; Tiffee A; Hockensmith A; Zeng H; Jones GN; Musso MW
Am J Emerg Med; 2017 Oct; 35(10):1506-1509. PubMed ID: 28457767
[TBL] [Abstract][Full Text] [Related]
14. Spice, vulnerability, and victimization: Synthetic cannabinoids and interpersonal crime victimization among homeless adults.
Ellsworth JT
Subst Abus; 2022; 43(1):32-38. PubMed ID: 31697191
[TBL] [Abstract][Full Text] [Related]
15. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
Every-Palmer S
Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
[TBL] [Abstract][Full Text] [Related]
16. Synthetic Cannabinoids.
Mills B; Yepes A; Nugent K
Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
[TBL] [Abstract][Full Text] [Related]
17. A public health approach to increased synthetic cannabinoid-related morbidity among New York City residents, 2014-2015.
Nolan ML; Allen B; Kunins HV; Paone D
Int J Drug Policy; 2016 Aug; 34():101-3. PubMed ID: 27453146
[No Abstract] [Full Text] [Related]
18. "Spice" girls: synthetic cannabinoid intoxication.
Schneir AB; Cullen J; Ly BT
J Emerg Med; 2011 Mar; 40(3):296-9. PubMed ID: 21167669
[TBL] [Abstract][Full Text] [Related]
19. Factors identifying high-frequency and low-frequency health service utilization among substance-using adults.
O'Toole TP; Pollini R; Gray P; Jones T; Bigelow G; Ford DE
J Subst Abuse Treat; 2007 Jul; 33(1):51-9. PubMed ID: 17588489
[TBL] [Abstract][Full Text] [Related]
20. Synthetic cannabinoid use in psychiatric patients and relationship to hospitalisation: A retrospective electronic case register study.
Hobbs M; Patel R; Morrison PD; Kalk N; Stone JM
J Psychopharmacol; 2020 Jun; 34(6):648-653. PubMed ID: 32108548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
